Technology offer : Leptospirosis Rapid Diagnostic Test
Leptospirosis is a growing public health concern in many tropical and subtropical countries. However, its diagnosis is difficult because of non-specific symptoms and concurrent other endemic diseases. In many regions the laboratory diagnosis is not available due to a lack of preparedness and simple diagnostic assay or difficult access to references laboratories.
The technology developed within the Pasteur Institute refers to the use of a new antigen for the detection of anti-leptospira human IgM. The technology has been developed in ELISA and Vertical flow rapid diagnostic test (RDT). First tries gives for ELISA a sensitivity of 94% and specificity of 99%, and the RDT shows a sensitivity of 90% and specificity of 94%.
Ref : OT-00107
Area of activity : HEALTH COSMETOLOGY
P: +33 (0)4 91 99 94 27